Key releases are ad hoc announcements pursuant to SIX Swiss Exchange Art. 53 LR
Latest press release
04 . 12 . 2025
Press release
Latest press releases and news stories
Go to news archive
Featured News Article
04/12/2025
Press release
Galderma secures ‘BBB’ credit rating with positive outlook from S&P Global Ratings
17/11/2025
Press release
ASDS 2025: Compelling new data on Restylane, Sculptra and Relfydess highlight Galderma’s innovative Injectable Aesthetics portfolio and pipeline
14/11/2025
Press release
Galderma completes successful placement of CHF 175 million bond
10/11/2025
News story
ASDS 2025: Galderma’s scientific presentations
05/11/2025
Press release
Galderma receives U.S. FDA approval for Restylane® Lyft™ for the enhancement of the chin profile
29/10/2025
News story
Two patients, one condition: the overlooked impact of atopic dermatitis on families
GALDERMA'S RESPONSE TO AESTHETIC IMPACT OF MEDICATION-DRIVEN WEIGHT LOSS
Discover key insights from the first international consensus guidelines in the full report.
Galderma Annual Reports
MEDIA TOOLKIT: ATOPIC DERMATITIS
Access materials for additional information about the burden of atopic dermatitis.
MEDIA TOOLKIT: PRURIGO NODULARIS
Access materials for additional information about the burden of prurigo nodularis.
MEDIA TOOLKIT: SENSITIVE SKIN AND MODERN LIFESTYLES
Galderma’s scientific response to a growing dermatological challenge.
MEDIA TOOLKIT: MEDICATION-DRIVEN WEIGHT LOSS
Understanding the aesthetic impacts of significant and rapid weight loss.
GET IN TOUCH WITH
25.08.2025
Press release
17.06.2025
Press release
